novel
small
molecul
thiocarbaz
pubchem
sid
potent
inhibitor
human
cathepsin
l
ec
ic
nm
develop
follow
compound
screen
nih
molecular
librari
small
molecul
repositori
hr
preincub
cathepsin
l
compound
becam
even
potent
demonstr
ic
nm
thiocarbaz
determin
slowbind
slowli
revers
competit
inhibitor
transient
kinet
analysi
singlestep
revers
inhibit
rate
constant
k
k
k
nm
molecular
dock
studi
undertaken
use
experimentallyderiv
xray
crystal
structur
studi
reveal
critic
hydrogen
bond
pattern
thiocarbaz
key
activ
site
residu
papain
thiocarbaz
display
greater
select
toward
cathepsin
l
papain
cathepsin
b
k
v
activ
cathepsin
g
inhibitor
demonstr
lack
toxic
human
aortic
endotheli
cell
zebrafish
addit
thiocarbaz
inhibit
vitro
propag
malaria
parasit
plasmodium
falciparum
ic
inhibit
leishmania
major
ic
cathepsin
famili
ubiquit
lysosom
proteas
demonstr
import
physiopatholog
role
inflamm
osteoand
rheumatoid
arthriti
osteoporosi
alzheim
diseas
multipl
sclerosi
pancreat
apoptosi
liver
disord
lung
disord
myocardi
disord
diabet
muscular
dystrophi
tumor
invas
metastasi
fujishima
et
al
leist
jaattela
nomura
katunuma
turk
guncar
cathepsin
l
endopeptidas
catalyt
activ
known
lysosom
cystein
proteas
otto
schirmeist
papainlik
cystein
proteas
interest
due
involv
mani
biolog
process
includ
epiderm
homeostasi
hair
follicl
morphogenesi
cycl
extracellular
matrix
degrad
viral
entri
sever
acut
respiratori
syndrom
sar
coronaviru
ebola
viru
hendra
viru
chandran
et
al
nomura
katunuma
pager
dutch
simmon
et
al
turk
et
al
due
role
mani
cathepsin
llike
proteas
diseas
malaria
falcipain
leishmaniasi
leishmania
major
cathepsin
l
chaga
diseas
cruzipain
african
trypanosomiasi
congopain
toxoplasmosi
toxoplasma
gondii
cathepsin
l
amoebiasi
histolysain
sleep
sick
rhodesain
inhibitor
human
cathepsin
l
may
highli
valuabl
therapeut
treatment
infecti
diseas
part
nation
institut
health
molecular
librari
screen
center
network
nih
mlscn
penn
center
molecular
discoveri
pcmd
perform
high
throughput
screen
ht
variou
target
deposit
data
pubchem
develop
small
molecul
probe
high
throughput
screen
compound
nih
molecular
librari
small
molecul
repositori
biofocu
dpi
san
francisco
ca
perform
human
cathepsin
l
averag
factor
screen
indic
good
plate
uniform
throughout
run
zhang
et
al
result
screen
avail
pubchem
bioassay
major
constitu
potent
hit
high
throughput
screen
sid
figur
appar
ic
nm
subsequ
determin
chemic
synthesi
structur
elucid
lcm
activ
compound
actual
ringopen
form
oxadiazol
sid
myer
et
al
sid
figur
stabl
bocprotect
senantiom
ringopen
byproduct
prove
potent
revers
human
cathepsin
l
inhibitor
although
thiocarbaz
inhibitor
cathepsin
yet
report
member
structur
similar
class
azapeptid
shown
effect
inhibitor
cystein
proteas
baggio
et
al
magrath
abel
thompson
et
al
xing
hanzlik
herein
report
biochem
biolog
character
molecular
dock
sid
novel
potent
select
thiocarbaz
inhibitor
human
cathepsin
l
cathepsin
l
assay
carri
use
zpheargamc
sigma
ngml
human
liver
cathepsin
l
calbiochem
reaction
plate
assay
buffer
consist
mm
sodium
acet
mm
ethylenediaminetetraacet
acid
edta
mm
cystein
ph
cathepsin
l
incub
assay
buffer
min
prior
dispens
well
allow
effici
reduct
activ
site
cystein
requir
full
enzymat
activ
amc
dilut
control
perform
inner
filter
effect
quench
observ
fluorophor
concentr
high
sid
synthes
describ
previous
myer
et
al
twofold
serial
dilut
dose
respons
sid
perform
determin
rel
potenc
cathepsin
l
well
corn
assay
plate
contain
water
inhibitor
rang
mm
nm
dimethyl
sulfoxid
dmso
posit
neg
control
present
serv
intern
control
dmso
transfer
place
inhibitor
ten
zpheargamc
five
time
concentr
assay
buffer
ngml
cathepsin
l
assay
buffer
ad
sequenti
initi
proteolyt
reaction
total
assay
buffer
dispens
place
enzym
neg
control
well
result
final
dose
respons
concentr
rang
nm
inhibitor
dmso
final
reaction
volum
fluoresc
intens
well
assay
plate
monitor
perkinelm
envis
micropl
reader
excit
nm
emiss
nm
measur
amc
releas
enzymecatalyz
hydrolysi
zpheargamc
data
scale
use
intern
control
fit
fourparamet
logist
model
idb
xlfit
equat
guildford
surrey
unit
kingdom
obtain
ic
valu
triplic
establish
timedepend
mechan
inhibit
enzym
inhibitor
preincub
variou
time
point
micropl
prior
addit
substrat
initi
enzymat
reaction
cathepsin
l
ngml
sid
variou
concentr
assay
buffer
incub
hr
five
zpheargamc
substrat
ad
plate
monitor
amc
hydrolysi
envis
fluoresc
micropl
reader
test
revers
sid
cathepsin
l
final
assay
concentr
ngml
inhibitor
ic
hr
preincub
combin
incub
hr
room
temperatur
mixtur
dilut
corn
plate
assay
buffer
contain
zpheargamc
final
volum
ul
rapidli
revers
inhibitor
dissoci
enzym
restor
greater
approxim
enzymat
activ
figur
fluoresc
intens
reaction
well
monitor
continu
amc
hydrolysi
envis
plate
reader
time
calcul
use
system
ordinari
differenti
equat
reaction
step
figur
progress
curv
inhibitor
concentr
fit
fiveparamet
k
k
k
k
k
cat
kinet
inhibit
model
use
appspack
optim
softwar
appspack
gener
solver
linearlyconstrain
optim
problem
griffin
kolda
sid
assay
inhibit
papain
cathepsin
b
g
k
v
papain
carica
papaya
calbiochem
ngml
human
cathepsin
k
calbiochem
ngml
human
spleen
cathepsin
calbiochem
ngml
human
cathepsin
v
calbiochem
ngml
assay
use
zpheargamc
substrat
respect
human
liver
cathepsin
b
calbiochem
ngml
assay
use
zargargamc
substrat
bachem
human
neutrophil
cathepsin
g
calbiochem
assay
use
sucalaalapropheamc
substrat
sigma
reaction
perform
mm
sodium
acet
buffer
contain
mm
cystein
mm
edta
ph
reaction
progress
monitor
use
envis
micropl
reader
ic
valu
measur
triplic
human
aortic
endotheli
cell
seed
corn
white
steril
tissu
culturetr
micropl
plate
centrifug
incub
hr
sid
doxorubicin
posit
control
serial
dilut
endotheli
cell
media
lonza
five
serial
dilut
ad
cell
triplic
result
final
concentr
compound
nm
dmso
plate
centrifug
incub
hr
thirti
promega
ad
well
centrifug
minut
luminesc
measur
use
envis
micropl
reader
eight
twofold
serial
dilut
sid
rpmi
media
invitrogen
contain
lglutamin
mgl
hypoxanthin
gl
hepe
albumax
ii
bovin
serum
invitrogen
sodium
bicarbon
gentamicin
perform
corn
micropl
ad
red
blood
cell
infect
synchron
ring
stage
luciferaseexpress
plasmodium
falciparum
parasit
parasitaemia
hematocrit
compound
result
final
concentr
test
nm
addit
normal
red
blood
cell
infect
red
blood
cell
ad
two
control
column
contain
media
plate
incub
humid
chamber
co
n
hr
allow
two
cycl
red
blood
cell
ruptur
invas
take
place
forti
promega
ad
well
centrifug
minut
luminesc
measur
use
envis
micropl
reader
five
thousand
leishmania
major
promastigot
plate
per
well
microtit
plate
volum
promastigot
growth
medium
promastigot
treat
concentr
rang
sid
hr
five
ad
per
well
incub
hr
rel
fluoresc
unit
captur
spectramax
microtit
plate
reader
dmso
concentr
held
constant
immedi
mix
enzym
substrat
inhibitor
preincub
enzym
inhibitor
sid
found
inhibit
human
cathepsin
l
ic
nm
preincub
enzym
hr
prior
substrat
addit
sid
display
increas
potenc
ic
valu
fall
nm
nm
nm
respect
demonstr
slow
onset
inhibit
target
enzym
figur
mechan
inhibit
determin
whether
compound
act
rapidli
revers
slowli
revers
irrevers
inhibitor
evalu
use
preincubationdilut
assay
copeland
preincub
human
cathepsin
l
compound
hr
ic
hr
preincub
nm
condit
creat
wherebi
enzym
enzymeinhibitor
complex
figur
upon
dilut
hr
preincub
mixtur
cathepsin
l
inhibitor
assay
buffer
contain
zpheargamc
substrat
approxim
enzymat
activ
return
reaction
comparison
substrat
convers
rate
preincub
uninhibit
reaction
figur
hr
preincub
enzymeinhibitor
reaction
condit
figur
reaction
inhibit
immedi
addit
substrat
due
almost
enzym
bound
small
molecul
inhibitor
sid
rate
product
format
hr
preincub
reaction
time
greater
initi
rate
product
format
show
inhibitor
releas
enzymeinhibitor
complex
enzymat
activ
inde
recov
therefor
sid
determin
slowli
revers
inhibitor
human
cathepsin
l
human
cathepsin
l
cleavag
zpheargamc
k
k
cat
determin
initi
rate
analysi
respect
figur
nonlinear
regress
transient
dynam
conduct
base
reaction
scheme
shown
figur
valu
k
k
k
k
explicitli
estim
rather
combin
equilibrium
paramet
k
k
estim
tradit
kinet
analys
best
fit
paramet
k
k
k
cat
k
k
figur
regress
k
nm
quit
consist
measur
ic
nm
obtain
hr
preincub
human
cathepsin
l
sid
explor
altern
model
inhibit
data
fit
model
irrevers
inhibitor
bind
inhibitor
bind
enzymesubstr
complex
model
fail
reproduc
data
well
fiveparamet
model
describ
revers
singlestep
competit
inhibit
return
activ
shown
figur
demonstr
thiocarbaz
revers
inhibitor
transient
kinet
analys
figur
quantifi
rate
revers
investig
mechan
revers
gener
put
leav
group
stoichiometr
reaction
cathepsin
l
sid
analyz
liquid
chromatographymass
spectrometri
shimadzu
mm
mm
premier
column
mlmin
step
water
acetonitril
min
hold
time
mobil
phase
contain
formic
acid
potenti
thiol
leav
group
form
reaction
cathepsin
l
thiocarbaz
carbonyl
sid
synthes
mw
detect
lcm
concentr
nm
retent
time
min
suppress
detect
due
presenc
human
cathepsin
l
howev
thiol
leav
group
detect
lcm
hr
incub
human
cathepsin
l
sid
result
argu
acyl
cathepsin
l
inhibitor
format
tetrahedr
intermedi
attack
activ
site
cy
residu
thiocarbaz
carbonyl
sid
exclud
fact
thiocarbaz
sulfur
sid
replac
carbon
result
molecul
much
weaker
inhibitor
ic
data
shown
sid
test
inhibitori
activ
papain
human
cathepsin
b
g
k
l
v
tabl
preincub
enzym
inhibitor
ic
valu
calcul
time
point
min
min
min
min
select
index
sid
ratio
ic
assay
proteas
divid
ic
cathepsin
l
rang
variou
papainlik
cystein
proteas
tabl
sid
inhibit
papain
cathepsin
b
k
v
ic
valu
determin
one
hour
rang
nm
expect
sid
show
inhibitori
activ
serin
proteas
cathepsin
g
ic
valu
systemat
decreas
time
proteas
demonstr
slowbind
natur
small
molecul
inhibitor
qualit
order
select
index
fairli
insensit
measur
taken
howev
weak
trend
observ
select
index
data
like
reflect
rel
rate
slowli
revers
inhibit
enzym
thu
would
appear
slowli
revers
reaction
proce
faster
cathepsin
v
cathepsin
l
wherea
proce
slowli
papain
sid
found
nontox
human
aortic
endotheli
cell
inhibitor
also
demonstr
lack
toxic
zebrafish
live
organ
assay
sid
activ
vitro
propag
assay
plasmodium
falciparum
ic
figur
addit
thiocarbaz
inhibitor
toxic
toward
leishmania
major
promastigot
ic
figur
cocryst
structur
bound
papain
tsuge
et
al
use
model
studi
hydrogen
bond
hydrophob
interact
thiocarbaz
inhibitor
sid
within
cystein
proteas
bind
site
chemic
structur
depict
figur
research
use
papain
design
highli
specif
cathepsin
inhibitor
directli
inhibit
cathepsin
l
lalond
et
al
tsuge
et
al
effort
construct
cathepsin
l
homolog
model
base
coordin
led
inconclus
dock
result
particularli
respect
arrang
critic
hydrophob
group
subsit
enzym
bind
pocket
cocryst
structur
coordin
human
cathepsin
l
complex
small
molecul
inhibitor
fujishima
et
al
would
prefer
howev
publicli
avail
residu
within
catalyt
bind
site
conserv
papain
cathepsin
l
includ
papain
make
direct
hydrogen
bond
contact
inhibitor
sinc
cathepsin
l
homolog
papain
within
papain
superfamili
cystein
proteas
high
resolut
structur
serv
excel
start
point
studi
small
molecul
inhibitor
cathepsin
l
molecular
dock
studi
sid
bind
site
papain
carri
use
xp
extra
precis
glide
softwar
predict
accur
bind
mode
accomplish
reason
accuraci
use
xp
glide
dock
result
computationallyderiv
proteinligand
complex
adequ
root
mean
squar
deviat
known
experimentallyderiv
cocryst
structur
perola
et
al
initi
dock
studi
conduct
system
order
verifi
xp
glide
could
reproduc
bind
mode
prepar
system
dock
coval
bond
papain
broken
epoxid
ringopen
form
independ
dock
papain
highest
score
pose
obtain
dock
studi
overlaid
well
experimentallyderiv
bound
inhibitor
figur
xp
glide
score
papain
kcalmol
valid
studi
interact
sid
papain
sid
prepar
dock
use
ligprep
softwar
highest
score
pose
sid
excel
score
kcalmol
score
close
xp
glide
score
obtain
independ
dock
papain
addit
mani
residu
made
contact
papain
also
involv
make
contact
sid
papain
figur
backbon
nh
hydrogen
made
direct
hydrogen
bond
contact
thiocarbaz
carbonyl
oxygen
sid
backbon
nh
hydrogen
made
hydrogen
bond
acyl
hydrazin
co
oxygen
ligand
backbon
carbonyl
oxygen
involv
hydrogen
bond
network
hydrazin
nh
amid
nh
sid
final
side
chain
nh
form
hydrogen
bond
amid
carbonyl
oxygen
sid
addit
group
sid
made
larg
hydrophob
contact
aromat
side
chain
locat
prime
region
enzym
bind
pocket
subsit
indol
group
sid
occupi
subsit
enzym
bind
pocket
dock
pose
sid
overlaid
figur
sid
look
remark
like
epoxid
ringopen
form
overlay
illustr
inhibitor
maintain
critic
distanc
two
carbonyl
group
dispos
relationship
intramolecular
distanc
sid
approxim
final
activ
site
sulfur
close
proxim
carbonyl
carbon
thiocarbaz
although
contribut
coval
bond
carbon
sulfur
directli
assess
dock
studi
molecul
sit
proper
orient
achiev
coval
bind
interact
figur
indic
howev
lack
compel
evid
coval
bind
enzym
sid
kinet
analys
demonstr
sid
highli
potent
select
competit
inhibitor
human
cathepsin
l
slow
bind
slow
revers
kinet
molecular
dock
sid
papain
crystal
structur
reveal
hydrophob
interact
within
subsit
hydrogen
bond
interact
interact
share
high
degre
similar
complex
tsuge
et
al
except
cathepsin
k
rang
select
index
sid
decreas
percent
ident
cathepsin
l
increas
may
due
strong
prefer
cathepsin
k
prolin
choe
et
al
interest
note
sid
time
potent
cathepsin
l
cathepsin
v
cathepsin
v
sometim
refer
cathepsin
share
amino
acid
sequenc
ident
cathepsin
l
shown
compens
role
cathepsin
l
epiderm
homeostasi
hair
follicl
morphogenesi
knockout
mice
hagemann
et
al
nagler
menard
reinheckel
et
al
use
coordin
system
abl
independ
dock
sid
bind
site
papain
led
conclus
sid
appear
bind
papain
manner
similar
five
residu
conserv
papain
cathepsin
l
make
direct
contact
inhibitor
addit
highli
hydrophobicaromat
site
involv
interact
hydrophob
group
sid
fact
sid
inhibit
malaria
leishmaniasi
suggest
act
cellular
system
requir
transit
across
lipid
membran
howev
micromolar
potenc
oppos
subnanomolar
potenc
purifi
human
cathepsin
l
surpris
sinc
measur
intern
concentr
inhibitor
achiev
organ
ii
activ
site
geometri
cathepsin
llike
cystein
proteas
might
differ
human
enzym
investig
sid
relat
analog
purifi
cathepsin
llike
enzym
falcipain
congopain
cruzipain
gondii
cathepsin
l
histolysain
rhodesain
warrant
base
find
studi
thiocarbaz
scaffold
readili
derivat
introduc
function
group
occupi
specif
bind
site
varieti
cystein
proteas
thu
hold
promis
gener
scaffold
design
specif
cystein
proteas
inhibitor
sever
acut
respiratori
syndrom
sid
substanc
identifi
dilut
protocol
determin
revers
cathepsin
l
final
assay
concentr
ngml
inhibitor
ic
hr
preincub
nm
combin
incub
hr
room
temperatur
mixtur
dilut
assay
buffer
contain
zpheargamc
rapidli
revers
inhibitor
dissoci
enzym
restor
greater
approxim
enzymat
activ
b
revers
data
sid
min
min
hr
hr
preincub
cathepsin
l
upon
dilut
assay
buffer
contain
zpheargamc
full
enzymesubstr
reaction
without
inhibitor
serv
posit
control
compar
initi
substrat
convers
rate
control
hr
preincub
studi
seen
enzymat
activ
restor
make
sid
slowli
revers
inhibitor
human
cathepsin
l
c
reaction
progress
curv
hr
preincub
cathepsin
l
sid
upward
curvatur
demonstr
enzym
recov
reaction
revers
rate
amc
releas
time
greater
initi
releas
rate
singlestep
mechan
simpl
revers
slow
bind
inhibit
govern
kinet
constant
k
k
b
k
k
cat
determin
human
cathepsin
l
enzymat
reaction
zpheargamc
substrat
k
k
cat
determin
respect
ordinari
differenti
equat
govern
singlestep
mechan
inhibit
shown
figur
b
reaction
progress
curv
shown
ngml
human
cathepsin
l
enzym
zpheargamc
substrat
vari
concentr
sid
inhibitor
fit
fiveparamet
inhibit
kinet
model
use
appspack
optim
softwar
linear
least
squar
object
function
ic
plasmodium
falciparum
determin
b
ic
leishmania
major
determin
cathepsin
lspecif
inhibitor
tsuge
et
al
b
overlay
crystal
structur
green
independ
dock
epoxid
ringopen
form
gray
xp
glide
score
topscor
pose
kcalmol
hydrogen
bond
interact
sid
papain
involv
catalyt
residu
distanc
sulfur
atom
thiocarbaz
carbonyl
carbon
carbon
like
undergo
nucleophil
attack
sulfur
b
overlay
light
green
comput
model
sid
papain
tan
strike
similar
bind
interact
two
inhibitor
select
index
sid
papain
human
cathepsin
b
g
k
l
v
